PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 9:37 AM ET

Sponsor Check › Person

TM
No photo found yet (own website and image search run after this page is viewed)

Thomas McKearn

Named as an officer, director or promoter on SEC Form D filings · NJ · Oct 1, 2009 → Feb 24, 2012

1deal (issuers)
$11.1Mreported sold
29investors
11Form D filings
2009–2012years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:20 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Thomas McKearn is listed as a director on 11 SEC Form D filings by 1 issuer between Oct 2009 and Dec 2012: Ayala Pharmaceuticals, Inc. (Monmouth Junction, NJ — biotechnology — 2009–2012; $11.1M reported sold to 29 investors).

What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.

Listed alongside James Patton (11 shared filings), John Rothman (11 shared filings), Richard Berman (11 shared filings), Roni A. Appel (11 shared filings), Thomas Moore (11 shared filings) and 2 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Thomas. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 1 bankruptcy case matching the name listed in Key records below.

What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 11 public filings for Thomas McKearn and found 12 differences, 5 worth asking the sponsor about: Amount sold went down between filings; Investor count went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Thomas McKearn has not run yet — it is joining a line of 36,961 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:20 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Thomas McKearn..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

1 case: 1 closed (disposition not in docket feed)

John McKearn and Dori McKearn closed
United States Bankruptcy Court, E.D. Wisconsin · No. 07-25229 · Filed Jul 9, 2007 · Closed Mar 27, 2009
Role of John McKearn and Dori McKearn: Debtor · Outcome: Case closed 2009-03-27 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (3 people in Form D filings, 1 federal dockets); different first name (john); court in WI (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:20 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

12 differences found between the filings for Thomas McKearn — 5 worth asking about (compared 11 filings on Oct 24, 2026)

Worth asking · Oct 5, 2009 – Oct 22, 2009

Amount sold went down between filings — Ayala Pharmaceuticals, Inc.

The Oct 5, 2009 filing says $5,000,000 sold; the Oct 22, 2009 Form D says $50,000 sold — $4,950,000 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Oct 5, 2009 ↗Form D (later) · Oct 22, 2009 ↗Ayala Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · Oct 1, 2009 – Oct 5, 2009

Investor count went down between filings — Ayala Pharmaceuticals, Inc.

The Oct 1, 2009 filing reports 7 investors; the Oct 5, 2009 Form D reports 1 investor.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D (earlier) · Oct 1, 2009 ↗Form D (later) · Oct 5, 2009 ↗Ayala Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · Oct 22, 2009

2221% of the money raised went to insiders — Ayala Pharmaceuticals, Inc.

The Oct 22, 2009 Form D reports $50,000 sold and $1,110,692 of the proceeds used for payments to officers, directors or promoters. Issuer's note: "Represents deferred salary and principal amount of a promissory note that the issuer owes the chief executive officer. The issuer may use the gross proceeds or other available funds for payments to t".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Oct 22, 2009 ↗Ayala Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Oct 1, 2009

19% of the money raised went to insiders — Ayala Pharmaceuticals, Inc.

The Oct 1, 2009 Form D reports $961,650 sold and $185,692 of the proceeds used for payments to officers, directors or promoters. Issuer's note: "Represents deferred salary that the issuer owes the chief executive officer, which is payable from the gross proceeds if certain amounts are raised in the offering as set forth in a Note Purchase Agre".

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Oct 1, 2009 ↗Ayala Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · Oct 22, 2009 – Nov 15, 2010

Paid seller listed without a CRD number: Evan Greenberg — Ayala Pharmaceuticals, Inc.

Evan Greenberg is listed as receiving sales compensation on 2 filings (Oct 22, 2009 to Nov 15, 2010) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Form D · Nov 15, 2010 ↗BrokerCheck search: Evan Greenberg ↗Ayala Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Worth asking · Jun 17, 2009 – Dec 13, 2012

4 Form Ds were filed more than 15 days after the first sale

Form D filed 106 days after the first sale — Ayala Pharmaceuticals, Inc. · Form D filed 30 days after the first sale — Ayala Pharmaceuticals, Inc. · Form D filed 19 days after the first sale — Ayala Pharmaceuticals, Inc. · Form D filed 46 days after the first sale — Ayala Pharmaceuticals, Inc.

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Oct 1, 2009 ↗Ayala Pharmaceuticals, Inc. — PartnerFacts page ↗Form D · Dec 13, 2012 ↗Form D · Jun 6, 2012 ↗
Sources
Note · Jun 17, 2009 – Dec 13, 2012

8 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Ayala Pharmaceuticals, Inc. (latest filing Dec 13, 2012) · No amendment in the last 12 months on an offering that may still be open — Ayala Pharmaceuticals, Inc. (latest filing Jun 6, 2012) · No amendment in the last 12 months on an offering that may still be open — Ayala Pharmaceuticals, Inc. (latest filing May 29, 2012) · No amendment in the last 12 months on an offering that may still be open — Ayala Pharmaceuticals, Inc. (latest filing Feb 24, 2012) · No amendment in the last 12 months on an offering that may still be open — Ayala Pharmaceuticals, Inc. (latest filing Nov 15, 2011) · and 3 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Dec 13, 2012 ↗Ayala Pharmaceuticals, Inc. — PartnerFacts page ↗Form D · Jun 6, 2012 ↗Form D · May 29, 2012 ↗
Sources
Note · Oct 5, 2009 – Oct 22, 2009

Offering amount changed between filings — Ayala Pharmaceuticals, Inc.

The Oct 5, 2009 filing says $5,000,000 offered; the Oct 22, 2009 Form D says an indefinite amount.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Oct 5, 2009 ↗Form D (later) · Oct 22, 2009 ↗Ayala Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Oct 1, 2009 – Oct 5, 2009

Offering amount changed between filings — Ayala Pharmaceuticals, Inc.

The Oct 1, 2009 filing says an indefinite amount offered; the Oct 5, 2009 Form D says $5,000,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Oct 1, 2009 ↗Form D (later) · Oct 5, 2009 ↗Ayala Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
Note · Oct 1, 2009 – May 29, 2012

Thomas McKearn is written 2 different ways on the filings

listed as "Thomas McKearn" on 8 filings (from Oct 1, 2009), and "Thomas L. McKearn" on 3 filings (from May 29, 2012).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Oct 1, 2009 ↗Form D · May 29, 2012 ↗Thomas McKearn — PartnerFacts page ↗
Sources
Note · Oct 23, 2015

Same name, different state: "Thomas McKearn" (PA) is a separate record

This page covers filings where the address state is NJ. A separate record, "Thomas McKearn" with address state PA, is listed on 1 filing — most recently by Traws Pharma, Inc. (Oct 23, 2015). The two records do not overlap in time: this page runs Oct 1, 2009 to Feb 24, 2012; the other has one filing dated Oct 23, 2015.

What this means Could be the same person who moved, or two people with the same name. We keep them apart until a filing ties them together. Check both pages before you decide.

Thomas McKearn (PA) — PartnerFacts page ↗Form D · Oct 23, 2015 ↗Traws Pharma, Inc. — PartnerFacts page ↗Thomas McKearn (NJ) — this page ↗
Sources
Note · Nov 15, 2010 – May 27, 2011

Address moved from North Brunswick, NJ to Princeton, NJ — Ayala Pharmaceuticals, Inc.

The people listed on the Nov 15, 2010 filing give North Brunswick, NJ; on the May 27, 2011 filing they give Princeton, NJ.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Nov 15, 2010 ↗Form D · May 27, 2011 ↗Ayala Pharmaceuticals, Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

4 of 9 offerings report sales commissions totalling $572,725; 2 report finder's fees totalling $52,750; 1 reports proceeds to related persons totalling $1,110,692.

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Dec 13, 2012 D
Ayala Pharmaceuticals, Inc.
File 021-188348
$0$0$0None listed on this filingEDGAR ↗
Jun 6, 2012 D
Ayala Pharmaceuticals, Inc.
File 021-179326
$28,000$0$0
No amount of the gross proceeds is anticipated to pay named executive officers, except that the issuer may use up to $200,000 of the gross proceeds or other available funds for payments to its CEO for prior outstanding amounts owed to him.
Rodman & Renshaw, LLC BrokerCheck CRD 16415 ↗EDGAR ↗
May 29, 2012 D
Ayala Pharmaceuticals, Inc.
File 021-178942
$0$0$0None listed on this filingEDGAR ↗
Feb 24, 2012 D
Ayala Pharmaceuticals, Inc.
File 021-173932
$73,325$0$0
No amount of the gross proceeds is anticipated to pay named executive officers, except that the issuer may use up to $200,000 of the gross proceeds or other available funds for payments to its CEO for prior outstanding amounts owed to him.
Rodman & Renshaw, LLC BrokerCheck CRD 16415 ↗EDGAR ↗
Nov 15, 2011 D
Ayala Pharmaceuticals, Inc.
File 021-168732
$110,425$0$0
The notes purchased in this offering by Thomas A. Moore, Advaxis' Chairman and Chief Executive Officer, were paid for in exchange for the cancellation of $400,000.00 of outstanding indebtedness owed by Advaxis to Mr. Moore.
Rodman & Renshaw, LLC BrokerCheck CRD 16415 ↗EDGAR ↗
May 27, 2011 D
Ayala Pharmaceuticals, Inc.
File 021-160513
$360,975$0$0
No amount of the gross proceeds is anticipated to pay named executive officers, except that the issuer may use up to $200,000 of the gross proceeds or other available funds for payments to the chief executive officer for prior outstanding amounts owed to
Rodman & Renshaw, LLC BrokerCheck CRD 16415 ↗EDGAR ↗
Nov 15, 2010 D
Ayala Pharmaceuticals, Inc.
File 021-150531
$0$50,250$0
No amount of the gross proceeds is anticipated to pay named executive officers, except that the issuer may use the gross proceeds or other available funds for payments to the chief executive officer for the amounts owed to him of not less than $538,791.00
Matthew D. Eitner BrokerCheck CRD 3267261 ↗
via Laidlaw & Company (UK) Ltd. (CRD 119037 ↗)

Evan Greenberg no CRD number reported		EDGAR ↗
Jul 30, 2010 D
Ayala Pharmaceuticals, Inc.
File 021-145752
$0$0$0None listed on this filingEDGAR ↗
Oct 22, 2009 D
Ayala Pharmaceuticals, Inc.
File 021-73969
$0$2,500$1,110,692
Represents deferred salary and principal amount of a promissory note that the issuer owes the chief executive officer. The issuer may use the gross proceeds or other available funds for payments to the chief executive officer for the amounts owed to him.
Evan Greenberg no CRD number reportedEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 1

Every issuer that named Thomas McKearn on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

AP
Biotechnology

Ayala Pharmaceuticals, Inc.

Monmouth Junction, NJ · Oct 1, 2009 → Dec 13, 2012 · 11 filings
  • Dec 13, 2012 · D · $0 sold of $10,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 6, 2012 · D · $715,000 sold of Indefinite · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 29, 2012 · D · $4,473,673 sold of Indefinite · 29 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 24, 2012 · D · $1,047,500 sold of Indefinite · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 15, 2011 · D · $1,977,500 sold of Indefinite · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 27, 2011 · D · $6,016,250 sold of Indefinite · 24 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 15, 2010 · D · $835,000 sold of Indefinite · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 30, 2010 · D · $7,500,000 sold of $7,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 22, 2009 · D · $50,000 sold of Indefinite · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 5, 2009 · D · $5,000,000 sold of $5,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 1, 2009 · D · $961,650 sold of Indefinite · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $11.1M from 29 investors (100% of the $10M target) as of the latest filing. Thomas is listed as director on 11 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (1)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Thomas McKearn — PA, 1 issuer, Oct 23, 2015 → Oct 23, 2015 · no shared issuer

People around Thomas 7

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

RA
No photo found yet (own website and image search run after this page is viewed)
Person

Roni A. Appel

Director · 11 shared filings (1 issuer)

Listed on the same filings as Thomas McKearn. Their page shows their other deals.

TM
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas Moore

Executive Officer, Director · 11 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Thomas McKearn. Their page shows their other deals.

RB
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Berman

Director · 11 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Thomas McKearn. Their page shows their other deals.

JR
No photo found yet (own website and image search run after this page is viewed)
Person

John Rothman

Executive Officer · 11 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Thomas McKearn. Their page shows their other deals.

JP
No photo found yet (own website and image search run after this page is viewed)
Person

James Patton

Director · 11 shared filings (1 issuer)

Listed on the same filings as Thomas McKearn. Their page shows their other deals.

MR
No photo found yet (own website and image search run after this page is viewed)
Person

Mark J. Rosenblum

Executive Officer · 8 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Thomas McKearn. Their page shows their other deals.

FC
No photo found yet (own website and image search run after this page is viewed)
Person

Fredrick Cobb

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Thomas McKearn. Their page shows their other deals.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 1 issuer this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Thomas McKearn by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 1 issuer this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Thomas McKearn is listed on: none on file. No website or social profile named in Ayala Pharmaceuticals, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #113,205 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Monmouth Junction, NJ). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗New Jersey state courts — find the court ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

New Jersey Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Thomas McKearn appears on a new Form D, or when a court case or SEC action is matched to them. See plans →